Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Apr 2021 for Pandion Therapeutics, Inc., €713k.
Filing timeline
BuySaleRahul Kakkar
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Rahul Kakkar: trading record in brief
Rahul Kakkar is a declared insider of Pandion Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 21 July 2020 and 1 April 2021, the trades on record add up to 4 filings.
Purchases make up the whole of the open-market record (1 purchase, €218k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 1 April 2021 came the latest disclosure, a transaction for €713k in Pandion Therapeutics, Inc. The most recent open-market purchase was published on 21 July 2020, 2,285 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rahul Kakkar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
14,000 shares@ US$60.001.9% of flowCommon StockSEC:0000899243-21-014453:0
702,515 shares@ US$60.0097.5% of flowCommon StockSEC:0000899243-21-014453:1
14,000 shares@ US$18.00100.0% of flowCommon StockSEC:0000899243-20-019869:1
Canonical exit: 19 Oct 2020 (T+90)
21,133 sharesCommon StockSEC:0000899243-20-019869:0
4 of 4 declarations
